Metabolic syndrome and pre ‐diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways

ConclusionsThe results of this study will determine if the metabolic syndrome and pre‐diabetes contribute to racial disparities in breast cancer mortality. It may provide the basis for targeting systemic insulin resistance and/or tumour insulin receptor signalling to reduce racial disparities in breast cancer mortality. Copyright © 2016 John Wiley & Sons, Ltd.

Source: Diabetes/Metabolism Research and Reviews - April 20, 2016 Category: Endocrinology Authors: Emily J. Gallagher, Derek LeRoith, Rebeca Franco, Irini Markella Antoniou, Anupma Nayak, Jennifer Livaudais ‐Toman, Nina A. Bickell Tags: Research Article Source Type: research